Losartan

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C22H23ClN6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JMS50MPO89, chemically known as 1h-imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1- biphenyl)-4-yl)methyl)- but generally known as losartan, which bears US NIH Compound Identifier 3961. European Medicines Agency schedules Losartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08593MIG. The term LOSARTAN is an International Non-Proprietary Name. World Health Organization schedules losartan in its Anatomical Therapeutic Chemical (ATC) Classification. LOSARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule losartan under HS 29332990 and SITC 51573. As of Q4 2014, LOSARTAN remains the US FDA Preferred Term for this commodity. Losartan bears US NLM identifiers UMLS ID C0126174 and NCI Concept Code C66869. SMILES: Clc1nc(n(Cc2ccc(cc2)c2c(cccc2)c2n[nH]nn2)c1CO)CCCC.